12th EPP Life Sciences Pricing Forum 2023
Provisional Program
What's Next - Pricing in the New Reality
PRE-FORUM WORKSHOPS 17 October 2023
12.00 - 13.00
WELCOME LUNCH & REGISTRATIONS |
13.00 - 14.00
WORKSHOP 1 Workshop on International Reference Pricing: Best in class operations An interactive workshop to address the IRP topic from an operational point of view Current challenges, what works, what does not work; from a process, tool and data point of view. Pricia Team |
14.10 - 15.10
WORKSHOP 2 Marbls Tender Simulation Game: “Tender Nation” – from Planning to Winning
Marbls Team |
15.10 - 15.30
COFFEE BREAK |
15.30 - 16.30
WORKSHOP 3 Pricing in the AI Era: What practical use cases are already at play and how to enable them Learn how pharma and MedTech companies are using AI and ML to gain competitive advantage on topics like tender management, sales & revenue forecasting, pricing optimization, loss of exclusivity strategy and others… Reflect with experts on your company trajectory for these topics and what they entail from a change management perspective. Monitor Deloitte Team |
16.40 - 17.40
WORKSHOP 4 Practical Uses of AI in Pricing & Access Survey of AI techniques in Pricing & Market Access, reviewing applicability of each technique Predictive pricing, HTA decision outcomes, ChatGPT-style queries of price & access information stores, etc. Detailed hands on use of AI tools to tackle practical problems Eversana Team |
Conference Day - 1 18 October 2023
8.00 - 8.30
WELCOME COFFEE & REGISTRATION |
8.30 - 8.50
Welcome by the President of EPP - Pol Vanaerde - President - EPP Opening Remarks - Dare to Ask |
Session 1:
|
Session 1:
PRICING STRATEGIES TO COPE WITH NEW TRENDS AND NEW REGULATIONS
|
---|---|
8.50 - 9.20
Understanding New Regulations, New Trends and How to Adapt Alan Crowther - General Manager Global Pricing Access Solution - Eversana |
|
9.20 - 9.50
EU Pharmaceutical Legislative Review: Impact on market access, pricing and reimbursement across countries Thomas Bols - Head of Government Affairs and Patient Advocacy, EMEA & APAC - PTC Therapeutics |
|
9.50 - 10.20
Pricing as a Lever During Inflationary Times Gianfranco Parlato - Head of Global Pricing Excellence - Servier Pharmaceuticals |
|
10.20 - 10.40
The Political Perspective on New Pharma Regulations in Europe Emma Eatwell - Practice Director - Global Counsel |
|
10.40 - 11.10
COFFEE BREAK - BE BACK IN 30 MINUTES! |
|
11.10 - 11.40
Global Pricing, Net Pricing: What is inflation and why does it occur? Peter Zimmermann - Senior Director Professional Services - Model N |
|
11.40 - 12.10
State Innovation Waivers: Important lessons from the US Affordable Care Act. Sebastian Gensior - Founder - Slate Mountains Capital |
|
12.10 - 12.40
The Canadian Pricing & Market Access Model: A new emphasis on innovation? Neil Palmer - Strategic Advisor - PDCI |
|
12.40 - 13.40
"ASK ME ABOUT" ONE HOUR FOR LUNCH AND NETWORKING OPPORTUNITIES |
Session 2:
|
Session 2:
BUILDING SUSTAINABLE AND EQUITABLE PRICING MODELS
|
---|---|
13.40 - 14.10
Equitable Pricing, Differential Pricing and Fair Patient Access Laurene Redding - Global Head, Value, Access & Pricing - BeiGene
|
|
14.10 - 14.40
Navigating Patient Access and Equitable Pricing: Addressing Challenges and Exploring Solutions Michael Hemmann - Capability Lead Pricing, Contracting and Tendering - Boehringer Ingelheim Gianfranco Parlato - Head of Global Pricing Excellence - Servier Pharmaceuticals PANEL MODERATED BY: Alejandra Garitonandia - Industry Principal for Life Sciences - Vistex |
|
14.40 - 15.10
Understanding the Impact of Pricing Practices and Regulations on Equity and Equality Giovanny Leon - Global Healthcare Executive - Novartis |
|
15.10 - 15.40
COFFEE BREAK - BE BACK IN 30 MINUTES! |
|
15.40 - 15.50
EPP Remarks |
|
15.50 - 16.20
Supporting Sustainable Access Through Equitable Pricing Principles Benoît Donze - Director, EU Pricing & Reimbursement Lead - Amarin Corporation Enric Muñoz - Sr. Director, Global Market Access - Global Rx Pricing Head - Galderma Omar Ali - Former Advisor to NICE, Lecturer - University of Portsmouth PANEL MODERATED BY: Ian Tidswell - Co-Founder - Ideal Price |
|
16.20 - 16.50
Algorithms, Artificial Intelligence, and Big Data in Tender Pricing and Forecasting Praful Mehta - CEO - Vamstar |
|
16.50 - 17.20
Loss of Exclusivity Strategy – Setting up for success Marc Abels – Partner - Strategy, M&A & Analytics leader - Lifesciences – Monitor Deloitte |
|
17.20
Closing remarks |
Conference Day - 2 19 October 2023
8.00 - 8.30
WELCOME COFFEE |
8.30 - 8.40
Opening Remarks - The Magic Key |
Session 3:
|
Session 3:
PRICING CHALLENGES & OPPORTUNITIES HTA, RWE AND VBHC
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
8.40 - 9.00
Measuring Market Access Success Alan Crowther - General Manager Global Pricing Access Solution - Eversana |
||||||||||||
9.00 - 9.30
Value Based Contracting: How to realize it? Andrea Mantovani - VP Global Pharma Service - Alira |
||||||||||||
9.30 - 10.00
Use of Real World Data and Real World Evidence to Getting a Price Daniel Muscionico - Senior Lecturer - Faculty of Medicine of the University of Geneva, Institute of Global Health |
||||||||||||
10.00 - 10.30
How to align HTA and health care decision making in Switzerland Goedele van Haasteren - Swiss Ministry of Health - Bundesamt für Gesundheit |
||||||||||||
10.30 - 11.00
COFFEE BREAK - BE BACK IN 30 MINUTES! |
||||||||||||
11.00 - 11.30
Developing the Optimum Price Design for your Innovative Life Sciences Solution Ian Tidswell - Co-Founder - Ideal Price |
||||||||||||
11.30 - 12.00
|
||||||||||||
12.00 - 13.00
"THE MAGIC KEY" ONE HOUR FOR LUNCH AND NETWORKING OPPORTUNITIES |
Session 4:
|
Session 4:
INNOVATIVE STRATEGIES AND METHODS
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
13.00 - 13.30
Gross-to-Net Transparency in Pharma - Driving Transparent Decisions and Profits Christian Zuberer - Managing Director - Accenture |
||||||||||||
13.30 - 14.00
Pricing optimization through ‘Gross to Net’: An industry example Kaushal Kishore - Pricing Transformation Consultant - Merck |
||||||||||||
14.00 - 14.30
|
||||||||||||
14.30 - 15.00
COFFEE BREAK - BE BACK IN 30 MINUTES! |
||||||||||||
15.00 - 15.30
Can we afford a cure? Omar Ali - Former Advisor to NICE, Lecturer - University of Portsmouth |
||||||||||||
15.30 - 15.50
Tenders and Technology Trends - Watch Out for AI Abhishek Batla - Director Project Management - Model N Peter Zimmermann - Senior Director Professional Services - Model N |
||||||||||||
15.50 - 16.20
The Fast Growth of AI/ML: Key steps to safely employ these new tools and techniques Li Mowei - Global Pricing Analytic Innovation and North America - Sanofi Neil Palmer - Strategic Advisor - PDCI |
||||||||||||
16.20
Closing remarks |